Breaking the Cycle: Managing Hyperkalaemia for Long-Term Cardiorenal Protection
Webinar
•
AstraZeneca
About the CPD course
A virtual webinar; led by experts in the cardiorenal field. As well as outlining the guidelines around use of K+ binders to manage hyperkalaemia; our specialist speakers provide insights into the importance of achieving long-term cardiorenal protection for patients living with CKD and HF. Patient case studies that provide key information regarding clinical implementation are used to support healthcare professionals in daily practice to improve patient outcomes.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
